Cargando…

A European patient record study on diagnosis and treatment of chemotherapy-induced anaemia

PURPOSE: Patients with cancer frequently experience chemotherapy-induced anaemia (CIA) and iron deficiency. Erythropoiesis-stimulating agents (ESAs), iron supplementation and blood transfusions are available therapies. This study evaluated routine practice in CIA management. METHODS: Medical oncolog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ludwig, Heinz, Aapro, M., Bokemeyer, C., Glaspy, J., Hedenus, M., Littlewood, T.J., Österborg, A., Rzychon, B., Mitchell, D., Beguin, Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082648/ https://www.ncbi.nlm.nih.gov/pubmed/24659244 http://dx.doi.org/10.1007/s00520-014-2189-0

Ejemplares similares

Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy
por: Hedenus, Michael, et al.
Publicado: (2014)

Evaluation of anaemia in patients with multiple myeloma and lymphoma: findings of the European CANCER ANAEMIA SURVEY
por: Birgegård, Gunnar, et al.
Publicado: (2006)

Chemotherapy-Induced Neutropenia and Febrile Neutropenia in the US: A Beast of Burden That Needs to Be Tamed?
por: Boccia, Ralph, et al.
Publicado: (2022)

Darbepoetin alfa for treating chemotherapy-induced anemia in patients with a baseline hemoglobin level < 10 g/dL versus ≥10 g/dL: an exploratory analysis from a randomized, double-blind, active-controlled trial
por: Vansteenkiste, Johan, et al.
Publicado: (2009)

Darbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapy
por: Glaspy, J A, et al.
Publicado: (2002)

Effects of erythropoiesis-stimulating agents on survival and other outcomes in patients with lymphoproliferative malignancies: a study-level meta-analysis
por: Hedenus, Michael, et al.
Publicado: (2012)

Over- and under-prophylaxis for chemotherapy-induced (febrile) neutropenia relative to evidence-based guidelines is associated with differences in outcomes: findings from the MONITOR-GCSF study
por: Bokemeyer, Carsten, et al.
Publicado: (2017)

Epoetin-β treatment in patients with cancer chemotherapy-induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events
por: Aapro, M, et al.
Publicado: (2009)

Predictive modeling of the outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (MONITOR-GCSF study)
por: Aapro, M., et al.
Publicado: (2016)

Aplastic Anaemia: Problems of Diagnosis and of Treatment
por: Lewis, S. Mitchell
Publicado: (1969)

Effect of treatment with epoetin beta on short-term tumour progression and survival in anaemic patients with cancer: a meta-analysis
por: Aapro, M, et al.
Publicado: (2006)

Treatment-induced anaemia and its potential clinical impact in patients receiving sequential high dose chemotherapy for metastatic testicular cancer
por: Bokemeyer, C, et al.
Publicado: (2002)

Pharmacovigilance in practice: erythropoiesis-stimulating agents
por: Hedenus, Michael, et al.
Publicado: (2014)

A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy
por: Glaspy, J, et al.
Publicado: (2001)

A dose- and schedule-finding study of darbepoetin alpha for the treatment of chronic anaemia of cancer
por: Smith, R E, et al.
Publicado: (2003)

The Diagnosis and Treatment of Addison's (Pernicious) Anæmia
por: Lewis, J. T.
Publicado: (1933)

5610939 RARE ANAEMIA DISORDERS EUROPEAN EPIDEMIOLOGICAL PLATFORM (RADEEP)
por: Colombatti, R., et al.
Publicado: (2023)

Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations
por: Aapro, Matti, et al.
Publicado: (2017)

Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemia
por: Steinmetz, T., et al.
Publicado: (2013)

Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer
por: Smith, R E, et al.
Publicado: (2001)

The incidence of anticipatory nausea and vomiting after repeat cycle chemotherapy: the effect of granisetron.
por: Aapro, M. S., et al.
Publicado: (1994)

Macrocytic Anaemia: Not Always a Straightforward Diagnosis
por: Teixeira, Andreia M, et al.
Publicado: (2022)

Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting—introduction
por: Aapro, Matti
Publicado: (2018)

An Unusual Cause of Anaemia of Chronic Disease: Lisinopril-Induced Chronic Inflammatory State
por: Eyre, Toby, et al.
Publicado: (2011)

The Diagnosis in a Case of Pernicious Anæmia
por: Hawthorne, C. O.
Publicado: (1909)

Acute Anaemia: A Challenging Diagnosis
por: Costa, Rui, et al.
Publicado: (2018)

New e-health services for the European Network for Rare and Congenital Anaemias (e-ENERCA)
por: Vives Corrons, J L, et al.
Publicado: (2014)

Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting—concluding thoughts
por: Aapro, Matti
Publicado: (2018)

Cost-effectiveness of recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia.
por: Barosi, G., et al.
Publicado: (1998)

Antibodies to actin in autoimmune haemolytic anaemia
por: Felder, Kathrin M, et al.
Publicado: (2010)

Severest Anæmias: Their Infective Nature, Diagnosis and Treatment
Publicado: (1910)

Enhanced radiosensitivity in experimental tumours following erythropoietin treatment of chemotherapy-induced anaemia.
por: Thews, O., et al.
Publicado: (1998)

Randomised, phase III trial of epoetin-β to treat chemotherapy-induced anaemia according to the EU regulation
por: Fujisaka, Y, et al.
Publicado: (2011)

Diet-related greenhouse gas emissions assessed by a food frequency questionnaire and validated using 7-day weighed food records
por: Sjörs, Camilla, et al.
Publicado: (2016)

Anæmia in Practice: Pernicious Anæmia
Publicado: (1939)

Pernicious Anæmia and Aplastic Anæmia
Publicado: (1925)

Improving Outcomes of Chemotherapy: Established and Novel Options for Myeloprotection in the COVID-19 Era
por: Lyman, Gary H., et al.
Publicado: (2021)

Single‐dose NEPA versus an aprepitant regimen for prevention of chemotherapy‐induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy
por: Zelek, Laurent, et al.
Publicado: (2023)

Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy
por: Barrett-Lee, P J, et al.
Publicado: (2000)

Accuracy of clinical pallor in the diagnosis of anaemia in children: a meta-analysis
por: Chalco, Juan P, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_9kovi1h6ue4s051b36bpej9ak1